Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CorNova, a developer of next-generation endovascular products, has appointed Andrew Jay to its board of directors.
Subscribe to our email newsletter
Dr Jay is the managing partner of the Medical Solutions Fund of Siemens Venture Capital, the venture organization for Siemens.
Prior to joining Siemens Venture Capital, Dr Jay was an institutional investor-ranked medical technology analyst with both Alex Brown and Wachovia Securities, where his coverage included cardiovascular device companies.
Dr Jay has received his DMD from the University of Pennsylvania and his MBA from the Kellogg School at Northwestern. Dr Jay has earned his BS from Rensselaer Polytechnic Institute.
Eric Ryan, CEO of CorNova, said: “Adding such an accomplished and experienced venture investor and medical technology analyst to our board is an important step in the development of CorNova. His advice will be invaluable as our company advances our FiberHalo angioplasty catheter toward commercialization, and we move forward to CE-Mark approval for our Valecor platinum coronary stent system.”